Ionix Pharmaceuticals, a privately held company founded in 2001 and based in Cambridge UK, is a leader in discovering and developing analgesic medicines for acute and chronic pain. Using proprietary drug targets and advanced chemistry, the company focuses on creating medicines to alleviate pain associated with trauma, surgeries, and debilitating diseases like arthritis, diabetes, and multiple sclerosis.